4,10-Dihydro-4-oxo-4 H -imidazo[1,2- a ]indeno[1,2- e ]pyrazin-2-carboxylic acid derivatives

This publication has 11 references indexed in Scilit:

• Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist
  Drug Development Research, 1999
• Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo
  Bioorganic & Medicinal Chemistry Letters, 1999
• AMPA receptor antagonists
  Expert Opinion on Therapeutic Patents, 1999
• The Role of Excitotoxicity in Neurodegenerative Disease
  Pharmacology & Therapeutics, 1999
• ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma
  Proceedings of the National Academy of Sciences, 1998
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes
  European Journal of Pharmacology, 1993
• A Rapid Filtration Assay for the Glycine Binding Site on the NMDA Receptor in Rat Cortical Membranes using [3H]Dichlorokynurenic Acid
  Journal of Pharmacy and Pharmacology, 1992
• Chaotropic Ions Affect the Conformation of Quisqualate Receptors in Rat Cortical Membranes
  Journal of Neurochemistry, 1988
• Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonist
  European Journal of Pharmacology, 1987
• Purines, pyrimidines, and imidazoles. Part 58. Synthesis and reactions of some imidazole-2,4-dicarboxylic acid derivatives
  Journal of the Chemical Society, Perkin Transactions 1, 1983